Frazier Life Sciences Management, L.P.
Position in ALLO — Allogene Therapeutics, Inc.
CIK 1892134
PALO ALTO, CA
Position in ALLO
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$9,263,869
+$3,963,682 QoQ
Shares Held
3,796,668
-1.9% QoQ
Ownership
1.10%
of shares outstanding
% of Portfolio
0.24%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALLO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Frazier Life Sciences Management, L.P. holds $3,802,745,091 across 34 Biotechnology names. ALLO ranks #31 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MIRM |
Mirum Pharmaceuticals, Inc.
|
7,679,684 | $709,449,207 | |
| 2 | NAMS |
NewAmsterdam Pharma Co N.V.
|
16,943,774 | $542,370,205 | |
| 3 | ERAS |
Erasca, Inc.
|
24,675,188 | $399,244,541 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
3,448,139 | $256,058,802 | |
| 5 | ARQT |
Arcutis Biotherapeutics, Inc.
|
9,874,511 | $232,643,479 | |
| 6 | MBX |
MBX Biosciences, Inc.
|
6,652,013 | $198,562,588 | |
| 7 | PHAT |
Phathom Pharmaceuticals, Inc.
|
12,466,489 | $138,502,692 | |
| 8 | MAZE |
Maze Therapeutics, Inc.
|
4,567,274 | $136,333,128 |
All Filings in ALLO
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $9,263,869 | 3,796,668 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $5,300,187 | 3,868,750 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $4,797,250 | 3,868,750 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $4,371,687 | 3,868,750 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $5,648,375 | 3,868,750 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $6,108,307 | 2,867,750 | Shares | Sole | 2025-02-18 | |
| 2024-09-30 | $8,029,700 | 2,867,750 | Shares | Sole | 2024-11-15 | |
| 2024-06-30 | $6,681,857 | 2,867,750 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $12,818,842 | 2,867,750 | Shares | Sole | 2024-05-15 | |
| No filing history on record for this holder in this stock. | ||||||